Table 1.
Baseline characteristics of patients associated with LN classes.
Clinico-Pathological Characteristics | Total (n = 53) |
---|---|
Demographic Data | |
Female | 44 |
Male | 9 |
Age (years) (mean ± SD) | 35 ± 13 |
Paraclinical Data (mean ± SD) | |
Urea (mg%) | 89.89 ± 69.66 |
Creatinine (mg%) | 1.69 ± 1.79 |
eGFR (CKD-EPI) (mL/min) | 68.18 ± 40.84 |
Proteinuria 24 h (g/24 h) | 15.53 ± 46.97 |
Urine Protein/Creatinine Ratio | 4.9 ± 4.75 |
Hemoglobin (g%) | 10.15 ± 2.22 |
Leucocyte (/mm3 × 103) | 7.24 ± 4.71 |
Thrombocytes (/mm3 × 103) | 239.10 ± 114.67 |
ESR (mm/2 h) | 68.27 ± 41.06 |
Cholesterol (mg%) | 230.67 ± 79.61 |
Triglyceride (mg%) | 199.44 ± 76.13 |
Anti-dsDNA (IU/mL) | 209.49 ± 157.01 |
Anti-phospholipid (IU/mL) | 16.17 ± 10.36 |
Complement 3 (mg/dL) | 62.23 ± 26.78 |
Renal SLEDAI Score | 11.57 ± 2.71 |
Lupus Nephritis Classes | |
Class II | 2 |
Class III | 4 |
Class IV | 19 |
Class V | 22 |
Class VI | 6 |
eGFR (CKD-EPI): estimated filtration rate (Chronic Kidney Disease Epidemiology Collaboration); UPCR: urine protein/creatinine ratio; ESR: erythrocyte sedimentation rate; ds-DNA: double-stranded deoxyribonucleic acid; SLEDAI: systemic lupus erythematosus disease activity index; SD: standard deviation.